Iva VilasBoas-Ribeiro1, Sergio Curto1, Gerard C. van Rhoon1,2, and Margarethus M. Paulides1,3
1Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands, 2Department of Radiation Science and Technology, Faculty of Applied Sciences, Delft University of Technology, Delft, Netherlands, 3Center for Care and Cure Technologies Eindhoven (C3Te), Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands
Synopsis
Proton
resonant frequency shift is the most frequently used method for MR-thermometry.
This method is sensitive to patient motion which poses issues that affect the MR-thermometry
accuracy. Few studies have evaluated MR thermometry in the pelvis, but only in volumes far from the regions
with air motion, and without an objective patient data exclusion criteria.
In this study, we assessed accuracy of MR thermometry for a selected group of patients
with cervical carcinoma. We
showed that changing
gastrointestinal air volume was an important confounder for MR thermometry
accuracy and that this can be exploited for selection criteria prior to
treatment.
Introduction
The
efficacy of hyperthermia depends on the delivery of well controlled and precise
heating to the entire tumor volume without overheating the surrounding tissues.
Clinical trials have proved that the probability of cure is correlated with the
administered thermal dose1,2. The combination of a magnetic resonance
(MR)-compatible applicator within an MR-system to monitor the temperature
change non-invasively provides an ideal technological platform to achieve
dose-optimization in real-time. Proton resonant frequency shift (PRFS)3 is currently
the most frequently used method for MR-thermometry but is challenging in the
pelvic region. The PRFS method measures
temperature changes and it is considerably affected by moving air in the adjacent
intestines, causing susceptibility artifacts4. Earlier, a few studies5,6 investigated MR thermometry in the pelvis, but only in volumes far from
the regions with air motion, and undefined objective patient data inclusion criteria.
In this study, we assessed accuracy of MR thermometry versus intraluminal
temperature probes for a homogenous group of patients with cervical carcinoma. We
also investigated if intestinal air volume change at the beginning of the
treatment could be used for patient selection as predictor for MR thermometry accuracy.Methods
A total of fourteen patients diagnosed with primary or recurrent
cervical carcinoma were included in this
study. For each patient, on average three hyperthermia treatments were delivered
in the
BSD‑2000‑3D
MR‑compatible system (Pyrexar Medical Corp., Salt Lake City, UT, US)7
integrated in a 1.5 T GE Signa Excite scanner (General Electric
Healthcare, Waukesha, USA).
We
employed the PRFS method, where a dual-echo
gradient-echo (GRE) sequence was applied8 (TE=4.8 and 19.1 ms; TR=620 ms; 25 axial slices;
slice thickness=1 cm; FOV=50×50 cm2; acquisition
matrix=128×128; reconstruction matrix=256×256). Prior to application of RF
power, two reference scans were acquired to assess baseline conditions. In
addition to the four fat tubes included in the hyperthermia device (Figure 1), body
far was used to correct for changes of the static magnetic field B0. A 2D polynomial spatial-temporal
correction was applied across the MR temperature maps such that temperature
changes were reversed to zero in the selected fat regions. In addition, MR
thermometry was filtered such to avoid
pollution by data points affected by confounders like motion. The intraluminal
thermometry was acquired using high resistive (Bowman) probes. Average temperature was calculated for each time point within the
delineated region of interest (ROI) around the probe. MR thermometry accuracy
was quantified by the absolute temperature difference between the mean average
temperature in the ROI and the corresponding intraluminal temperature
measurement. The threshold for acceptable
MR thermometry accuracy was < 1°C9. The anatomic images of the reference scans were used to delineate
gastrointestinal air (Figure 1 and Figure 2). The gastrointestinal air volume
change was quantified by the
absolute change between the two reference scans. We selected the treatment
sessions based on the absolute gastrointestinal air change below or equal to 5
ml. After this selection, MR thermometry accuracy was evaluated for eight
patients (fifteen hyperthermia sessions).Results
The
average of gastrointestinal air volume change in all treatment sessions and in
the selected sessions was 20.7± 29.1 ml and 2.3±1.67 ml, respectively. Figure 3
presents the temperature distributions during the hyperthermia treatment of the
representative patient. We verified that the gastrointestinal air volume change
was 4.8 ml, which represents one of the patients with highest change between
the selected patients. Figure 4 presents an example of an unselected patient with
a gastrointestinal air volume change of 21.4 ml. As shown, most of the regions
where the probes are evaluated were filtered out due to high volumes of air.
Figure 5 presents the evaluation of MR
thermometry regarding to accuracy in all the patients and in the selected data,
where the median accuracy for all patients and
selected data was 1.73°C and 0.81°, respectively. Although more than 50% of the
selected sessions presented a MR thermometry accuracy within the limits, 46% of
the data was outside the acceptable threshold.
Conclusions
Conclusions: Our study showed that change in gastrointestinal air volume could be used as criteria for selection
of patients with higher accuracy in MR thermometry. We observed that, in comparison with including all sessions, the
selection distinguished a group that has higher MR thermometry accuracy by 53%.
This study indicated that changing gastrointestinal air volume was
an important confounder for MR thermometry accuracy and that this can be exploited
for imaging based selection prior to treatment. Acknowledgements
This
research has been made possible by the Dutch Cancer Society and the Netherlands
Organization for Scientific Research (NWO) as a part of their joint Partnership
Programme: “Technology for Oncology” grant number: 15195 and the Dutch Cancer
Society grant KWF-DDHK 2013-6072.References
1. Datta NR, Bodis S.
Hyperthermia with radiotherapy reduces tumour alpha/beta: Insights from trials
of thermoradiotherapy vs radiotherapy alone. Radiother Oncol.
2019;138:1-8.
2. Datta
NR, Stutz E, Gomez S, Bodis S. Efficacy and Safety Evaluation of the Various
Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and
Network Meta-Analysis of Randomized Clinical Trials. Int J Radiat Oncol Biol
Phys. 2019;103(2):411-437.
3. Poorter
J De, Wagter C De, Deene Y De, Thomsen C, Ståhlberg F, Achten E. Noninvasive
MRI Thermometry with the Proton Resonance Frequency (PRF) Method: In Vivo
Results in Human Muscle. Magn Reson Med. 1995;33(1):74-81.
4. Winter
L, Oberacker E, Paul K, et al. Magnetic resonance thermometry: Methodology,
pitfalls and practical solutions. Int J Hyperth. 2016;32(1):63-75.
5. Gellermann J, Wlodarczyk W,
Hildebrandt B, et al. Noninvasive
magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 tesla
hybrid system. Cancer Res. 2005;65(13):5872-5880.
6. Gellermann J, Hildebrandt B, Issels R,
et al. Noninvasive magnetic resonance thermography of soft
tissue sarcomas during regional hyperthermia: Correlation with response and
direct thermometry. Cancer. 2006;107(6):1373-1382.
7. Gellermann
J, Wlodarczyk W, Feussner A, et al. Methods and potentials of magnetic
resonance imaging for monitoring radiofrequency hyperthermia in a hybrid
system. Int J Hyperth. 2005;21(6):497-513.
8. Curto S, Aklan B, Mulder T, et al. Quantitative , Multi-institutional Evaluation of MR Thermometry Accuracy
for Deep-Pelvic MR- Hyperthermia Systems Operating in Multi-vendor MR-systems
Using a New Anthropomorphic Phantom. Cancers (Basel). 2019;11:1709.
9. V. V.
N. Kothapalli S, Altman MB, Zhu L, et al. Evaluation and selection of anatomic sites
for magnetic resonance imaging-guided mild hyperthermia therapy: a healthy
volunteer study. Int J Hyperth. 2018;34(8):1381-1389.